Clinical Trial Update: Feasibility and Efficiency Study of Leukemic Cell Mobilization With Plerixafor Injection

View source ↗

Summary

This clinical trial evaluated the feasibility and efficiency of mobilizing leukemic cells using the CXCR4 inhibitor plerixafor in patients with acute myeloid le…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Mozobil (Plerixafor) (Plerixafor)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Acute Myeloid Leukemia | Status: COMPLETED